Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/220360| Title: | Hepatocellular carcinoma: what are the differential costs compared to the general population? |
| Author: | Darbà, Josep Ascanio, Meritxell |
| Keywords: | Hepatologia Control de costos Carcinogènesi Economia de la salut Política sanitària Hepatology Cost control Carcinogenesis Medical economics Medical policy |
| Issue Date: | 1-Apr-2025 |
| Publisher: | Taylor & Francis |
| Abstract: | Hepatocellular carcinoma (HCC), which accounts for about 90% of all primary liver can-cer cases, is the fifth most common malignancy and the second leading cause of cancer-related mor-tality worldwide. This study aims to analyse the differential costs of HCC-related hospital admissionscompared to the general population in Spain (...) |
| Note: | Reproducció del document publicat a: https://doi.org/https://doi.org/10.1080/13696998.2025.2484073 |
| It is part of: | Journal of Medical Economics, 2025, vol. 28, num.1, p. 471-478 |
| URI: | https://hdl.handle.net/2445/220360 |
| Related resource: | https://doi.org/https://doi.org/10.1080/13696998.2025.2484073 |
| ISSN: | 1369-6998 |
| Appears in Collections: | Articles publicats en revistes (Economia) |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 892056.pdf | 3.1 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License
